Across TCGA pan-cancer cohorts, DSCR4 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated DSCR4 data layer compared with 19 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher DSCR4 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated DSCR4 expression acts as an unfavorable survival marker.

LUAD are the cancer types where DSCR4 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	II,III,IV	0.206	0.681	.029	3	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: DSCR4 tumor-vs-normal RNA expression · all DSCR4 data types